View
707
Download
1
Embed Size (px)
DESCRIPTION
Citation preview
April 8, 2013
Asiatic Health NewsClinical trial:A randomized controlled cross-over study of Flupenthixol + Melitracen in Functional Dyspepsia.BACKGROUND:Functional dyspepsia is a prevalent condition associated with diminished quality of life (QoL) and high economic burden.
AIM:To study the efficacy of a combination of Flupenthixol and Melitracen (F+M) with anxiolytic and antidepressant properties in functional dyspepsia using a randomized controlled cross-over design.
RESULTS: Twenty-five patients (14 females, 11 males; mean age = 34.3 +/- 9.9 years) were enrolled and 24 completed the 8-week study. There was a significant improvement in subjective global symptom relief with Flupenthixol + Melitracen vs. placebo (ITT: 73.9% vs. 26.1%, P = 0.001). No difference was noted whether the initial treatment was Flupenthixol + Melitracen or placebo. No significant side effects were noted.
CONCLUSIONS:A combination of Flupenthixol and Melitracen is safe and effective in the short-term treatment of functional dyspepsia. Flupenthixol + Melitracen is associated with significant improvement in Quality of Life independent of the presence of Anxiety & Depression.
Ref
: 1. A
limen
t Pha
rmac
ol T
her.
2008
Jun
1;2
7 (1
1): 1
148-
55.
Flupentixol BP 0.5 mg + Melitracen INN 10 mgA new dimension for treating Anxiety and Depression
ITT=Intent to treat
Courtesy By Now available in Alu-Alu Blister
74%26%
Antison(Flupenthixol + Melitracen)
Placbo
Functional Dyspepsia